Unknown

Dataset Information

0

Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-? Inhibition.


ABSTRACT: Antiatherosclerotic effects of tumor necrosis factor-? (TNF-?) blockade in patients with systemic inflammatory states are not conclusively demonstrated, which suggests that effects depend on the cause of inflammation. Macrophage LRP1 (low-density lipoprotein receptor-related protein 1) and apoE contribute to inflammation through different pathways. We studied the antiatherosclerosis effects of TNF-? blockade in hyperlipidemic mice lacking either LRP1 (M?LRP1(-/-)) or apoE from macrophages.Lethally irradiated low-density lipoprotein receptor (LDLR)(-/-) mice were reconstituted with bone marrow from either wild-type, M?LRP1(-/-), apoE(-/-) or apoE(-/-)/M?LRP1(-/-)(DKO) mice, and then treated with the TNF-? inhibitor adalimumab while fed a Western-type diet. Adalimumab reduced plasma TNF-? concentration, suppressed blood ly6C(hi) monocyte levels and their migration into the lesion, and reduced lesion cellularity and inflammation in both wild-type?LDLR(-/-) and apoE(-/-)?LDLR(-/-) mice. Overall, adalimumab reduced lesion burden by 52% to 57% in these mice. Adalimumab reduced TNF-? and blood ly6C(hi) monocyte levels in M?LRP1(-/-)?LDLR(-/-) and DKO?LDLR(-/-) mice, but it did not suppress ly6C(hi) monocyte migration into the lesion or atherosclerosis progression.Our results show that TNF-? blockade exerts antiatherosclerotic effects that are dependent on the presence of macrophage LRP1.

SUBMITTER: Zhu L 

PROVIDER: S-EPMC5346022 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.

Zhu Lin L   Giunzioni Ilaria I   Tavori Hagai H   Covarrubias Roman R   Ding Lei L   Zhang Youmin Y   Ormseth Michelle M   Major Amy S AS   Stafford John M JM   Linton MacRae F MF   Fazio Sergio S  

Arteriosclerosis, thrombosis, and vascular biology 20160630 8


<h4>Objective</h4>Antiatherosclerotic effects of tumor necrosis factor-α (TNF-α) blockade in patients with systemic inflammatory states are not conclusively demonstrated, which suggests that effects depend on the cause of inflammation. Macrophage LRP1 (low-density lipoprotein receptor-related protein 1) and apoE contribute to inflammation through different pathways. We studied the antiatherosclerosis effects of TNF-α blockade in hyperlipidemic mice lacking either LRP1 (MΦLRP1(-/-)) or apoE from  ...[more]

Similar Datasets

| S-EPMC3905798 | biostudies-literature
| S-EPMC4516847 | biostudies-literature
| S-EPMC7666429 | biostudies-literature
| S-EPMC5928146 | biostudies-literature
| S-EPMC1136900 | biostudies-other
| S-EPMC4712446 | biostudies-literature
| S-EPMC3716867 | biostudies-literature
| S-EPMC4390166 | biostudies-literature
| S-EPMC4617360 | biostudies-literature
| S-EPMC2943235 | biostudies-literature